Clinical Research Directory

Inclusion Criteria: * Male or female aged 18 years * Participant is having a urethral or suprapubic long-term catheter (LTC) in situ for more than 28 days and no plan for discontinuation of LTC at the time of recruitment * Currently using the LTC washout maintenance solution Uro-Tainer® Polihexanide 0.02% * Able to undertake LTC washouts or has a designated person (relative, friend, other informal carer, or paid/NHS healthcare worker) able to perform washouts * Able to complete the study documentation or has a designated person able to assist with study documentation * Informed consent obtained Exclusion Criteria: * Age younger than 18 years * Intermittent self catheterisation * Pregnant or contemplating pregnancy or breastfeeding * Ongoing S-CAUTI (until treatment is complete) * Visible haematuria (unless investigated/treated) * Known allergies to the LTC washout solution * Current bladder cancer (until treatment is complete and participant discharged from cancer surveillance program) * Known bladder stones (until treatment is complete) * Not able to communicate or to give consent including participants with incapacity to consent * Any other clinical and social reasons that would be deemed by the recruitment team to be unsuitable for the study * Simultaneous participation in another clinical trial * in case of hypersensitivity (allergy) to PHMB, chlorhexidine, or excipient of the solution. * several days after surgery on the bladder or the urinary tract * for open wounds, the inner and middle ear, the central nervous systems, eyes, hyaline cartilage, and meninges